The Infantile Spasms Therapeutics Market is witnessing robust growth, driven by increasing awareness, technological advancements, and a growing patient pool. Infantile spasms, a rare epileptic disorder typically affecting infants within the first year of life, necessitate prompt diagnosis and treatment. As the market evolves, several challenges and opportunities emerge, shaping its trajectory....

The Infantile Spasms Therapeutics market is experiencing notable growth, marked by significant developments and trends that underscore the industry's dedication to advancing treatments for pediatric neurological disorders. Here are key highlights shaping the current landscape: Market Growth: Pediatric Neurology Milestone: The Infantile Spasms Therapeutics market is witnessing a significant...